Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis
Background Studies have suggested that there is increased risk of thromboembolism (TE)
associated with coronavirus disease 2019 (COVID-19). However, overall arterial and …
associated with coronavirus disease 2019 (COVID-19). However, overall arterial and …
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence …
Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis
Background The association of pulmonary embolism (PE) with deep vein thrombosis (DVT)
in patients with coronavirus disease 2019 (COVID-19) remains unclear, and the diagnostic …
in patients with coronavirus disease 2019 (COVID-19) remains unclear, and the diagnostic …
Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis
Background Individual studies have reported widely variable rates for VTE and bleeding
among hospitalized patients with coronavirus disease 2019 (COVID-19). Research Question …
among hospitalized patients with coronavirus disease 2019 (COVID-19). Research Question …
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …
COVID-19: from an acute to chronic disease? Potential long-term health consequences
V Higgins, D Sohaei, EP Diamandis… - Critical reviews in …, 2021 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Despite pulmonary impairments being the most …
syndrome coronavirus 2 (SARS-CoV-2). Despite pulmonary impairments being the most …
Extrapulmonary manifestations of COVID-19
A Gupta, MV Madhavan, K Sehgal, N Nair… - Nature medicine, 2020 - nature.com
Although COVID-19 is most well known for causing substantial respiratory pathology, it can
also result in several extrapulmonary manifestations. These conditions include thrombotic …
also result in several extrapulmonary manifestations. These conditions include thrombotic …
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
Abstract Background COVID-19-associated coagulopathy (CAC) characterized by the
elevated D-dimer without remarkable changes of other global coagulation markers is …
elevated D-dimer without remarkable changes of other global coagulation markers is …
Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 …
NS Hendren, JA De Lemos, C Ayers, SR Das, A Rao… - Circulation, 2021 - Am Heart Assoc
Background: Obesity may contribute to adverse outcomes in coronavirus disease 2019
(COVID-19). However, studies of large, broadly generalizable patient populations are …
(COVID-19). However, studies of large, broadly generalizable patient populations are …
COVID-19 and venous thromboembolism: a meta-analysis of literature studies
A Di Minno, P Ambrosino, I Calcaterra… - … in thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations,
leading in some cases to a critical condition with poor long-term outcomes and residual …
leading in some cases to a critical condition with poor long-term outcomes and residual …